Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To determine what dosing regimen of atazanavir (ATV) / ritonavir (RTV) produces adequate drug
exposure during pregnancy compared to drug exposure in historical data in human
immunodeficiency virus (HIV) infected participants.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate Lamivudine, zidovudine drug combination Ritonavir